PacificHealth Laboratories Announces Sale of Sports Drink Assets to Mott's LLP

PacificHealth Laboratories Announces Sale of Sports Drink Assets to Mott's LLP Company announces that Mott's LLP, has purchased the trademarks, technology and patents for their brands, Accelerade(R) and Endurox (R) R4 (R), in return for a $4 million upfront payment and a royalty based on sales for a defined period. PacificHealth Laboratories was granted an exclusive royalty-free license to use the intellectual property and trademarks for the continued manufacture, distribution and marketing of Accelerade and Endurox R4 brands in powder and gel forms.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Wayne Bos Joins Natrol as CEO Designate Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions." Wayne Bos Joins Natrol as CEO Designate Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions." Wayne Bos Joins Natrol as CEO Designate Board of Directors has elected Wayne Bos as the Company's Chief Executive Officer and President designate, to assume his new duties next month. Plans include "to develop Natrol as a solid, profitable growth company, to focus on growing internationally and to ensure that we are opportunistic with regard to acquisitions." Wild Oats Markets Reports Fourth Quarter and Full-Year 2005 Results Company reports net sales of $1.1 billion for the year, up 7.2% over prior year, with net income of $0.11 per diluted share versus a net loss of $1.38 per diluted share for 2004. Q4 sales were $282.7 million versus $281.9 million for Q4 prior year, as comparable store sales increased 4.2%. Wild Oats Markets Reports Fourth Quarter and Full-Year 2005 Results Company reports net sales of $1.1 billion for the year, up 7.2% over prior year, with net income of $0.11 per diluted share versus a net loss of $1.38 per diluted share for 2004. Q4 sales were $282.7 million versus $281.9 million for Q4 prior year, as comparable store sales increased 4.2%. B&D Nutritional Ingredients, Inc., Announces Xsto Solutions to Represent Principals in the Northeast Company announces a business sales agent relationship with Xsto Solutions under which Xsto Solutions will be representing B&D in the Northeast. B&D Nutritional Ingredients, Inc., Announces Xsto Solutions to Represent Principals in the Northeast Company announces a business sales agent relationship with Xsto Solutions under which Xsto Solutions will be representing B&D in the Northeast. B&D Nutritional Ingredients, Inc., Announces Xsto Solutions to Represent Principals in the Northeast Company announces a business sales agent relationship with Xsto Solutions under which Xsto Solutions will be representing B&D in the Northeast. B&D Nutritional Ingredients, Inc., Announces Xsto Solutions to Represent Principals in the Northeast Company announces a business sales agent relationship with Xsto Solutions under which Xsto Solutions will be representing B&D in the Northeast. WellGen, Inc., Leading Nutrigenomics Company, Completes $3MM Series B Financing Company announces the completion of its Series B financing totaling $3MM with capital raised to provide additional resources for WellGen to begin clinical studies in humans under its Obesity and Inflammation Programs. WellGen, Inc., Leading Nutrigenomics Company, Completes $3MM Series B Financing Company announces the completion of its Series B financing totaling $3MM with capital raised to provide additional resources for WellGen to begin clinical studies in humans under its Obesity and Inflammation Programs. Balchem Corporation Announces Fourth Quarter 2005 Results Company reports net sales for the quarter of of $23.1 million, compared to $18.0 million for the comparable prior year, with sales in the Encapsulated/Nutritional Products segment of $9.4 million in the period, up50.3% from the prior year comparable quarter, including $1.5 million of sales from the Loders Croklaan acquisition. Balchem Corporation Announces Fourth Quarter 2005 Results Company reports net sales for the quarter of of $23.1 million, compared to $18.0 million for the comparable prior year, with sales in the Encapsulated/Nutritional Products segment of $9.4 million in the period, up50.3% from the prior year comparable quarter, including $1.5 million of sales from the Loders Croklaan acquisition. New VP of Sales & Marketing Hired by Nussentials Provider and distributor for a line of wellness and nutritional products based primarily on stabilized rice bran has announced that Charlie Milstead, Jr. has been hired as the new Vice President of Sales and Marketing. New VP of Sales & Marketing Hired by Nussentials Provider and distributor for a line of wellness and nutritional products based primarily on stabilized rice bran has announced that Charlie Milstead, Jr. has been hired as the new Vice President of Sales and Marketing. New VP of Sales & Marketing Hired by Nussentials Provider and distributor for a line of wellness and nutritional products based primarily on stabilized rice bran has announced that Charlie Milstead, Jr. has been hired as the new Vice President of Sales and Marketing. New VP of Sales & Marketing Hired by Nussentials Provider and distributor for a line of wellness and nutritional products based primarily on stabilized rice bran has announced that Charlie Milstead, Jr. has been hired as the new Vice President of Sales and Marketing. Omega Expands Corporate Positions With New COO Omega Biotech Corporation will expand its corporate officers to now include a Chief Operating Officer - candidates now being sought. Omega Expands Corporate Positions With New COO Omega Biotech Corporation will expand its corporate officers to now include a Chief Operating Officer - candidates now being sought. Omega Expands Corporate Positions With New COO Omega Biotech Corporation will expand its corporate officers to now include a Chief Operating Officer - candidates now being sought. Omega Expands Corporate Positions With New COO Omega Biotech Corporation will expand its corporate officers to now include a Chief Operating Officer - candidates now being sought. Olive Products Australia and C.K. Foods Inc. Enter Into Exclusive Distribution Agreement for Canadian Market Olive Products Australia and C.K. Foods Inc. enter into exclusive agreement under which C.K. foods will manage bulk sales of Fresh Olive Leaf Complex across Canada and to selected U.S. accounts. Olive Products Australia and C.K. Foods Inc. Enter Into Exclusive Distribution Agreement for Canadian Market Olive Products Australia and C.K. Foods Inc. enter into exclusive agreement under which C.K. foods will manage bulk sales of Fresh Olive Leaf Complex across Canada and to selected U.S. accounts. Olive Products Australia and C.K. Foods Inc. Enter Into Exclusive Distribution Agreement for Canadian Market Olive Products Australia and C.K. Foods Inc. enter into exclusive agreement under which C.K. foods will manage bulk sales of Fresh Olive Leaf Complex across Canada and to selected U.S. accounts. Olive Products Australia and C.K. Foods Inc. Enter Into Exclusive Distribution Agreement for Canadian Market Olive Products Australia and C.K. Foods Inc. enter into exclusive agreement under which C.K. foods will manage bulk sales of Fresh Olive Leaf Complex across Canada and to selected U.S. accounts. Galaxy Nutritional Foods Reports Third Quarter and Nine-Month Operating Results Company reports sales for FY06 Q3 of approximately $9.1 million, compared with net sales of approximately $10.6 million in the third quarter of FY2005,with a net loss to common stockholders of ($11,754,981), or ($0.59) per share, compared to ($1,061,807), or ($0.06) per share, in the prior-year quarter. Galaxy Nutritional Foods Reports Third Quarter and Nine-Month Operating Results Company reports sales for FY06 Q3 of approximately $9.1 million, compared with net sales of approximately $10.6 million in the third quarter of FY2005,with a net loss to common stockholders of ($11,754,981), or ($0.59) per share, compared to ($1,061,807), or ($0.06) per share, in the prior-year quarter. Herbalife Ltd. Announces Fourth-Quarter Net Sales and Full Year 2005 Net Sales Company reports Q4 net sales of $409.0 million, an increase of 19.7 percent compared to the same period of 2004, with net income of $30.0 million, or $0.41 per diluted share compared to a net loss of $37.4 million, or $0.68 per diluted share in 2004. Herbalife Ltd. Announces Fourth-Quarter Net Sales and Full Year 2005 Net Sales Company reports Q4 net sales of $409.0 million, an increase of 19.7 percent compared to the same period of 2004, with net income of $30.0 million, or $0.41 per diluted share compared to a net loss of $37.4 million, or $0.68 per diluted share in 2004. NutraCea Triples Capacity by Entering into Rice Bran Supply Agreement with Louisiana Rice Mill LLC Under the terms of the agreement, Louisiana Rice Mill (LRM) will supply raw rice bran from its rice milling operations to NutraCea. NutraCea Triples Capacity by Entering into Rice Bran Supply Agreement with Louisiana Rice Mill LLC Under the terms of the agreement, Louisiana Rice Mill (LRM) will supply raw rice bran from its rice milling operations to NutraCea. SunOpta Announces 2005 Year End Results Company reports revenues of $122,070,000, a 48% increase over the comparable quarter in 2004, with net earnings in the quarter of $1,559,000 or $0.03 per diluted common share, compared to $353,000 or $0.01 per diluted share in the same period in 2004. SunOpta Announces 2005 Year End Results Company reports revenues of $122,070,000, a 48% increase over the comparable quarter in 2004, with net earnings in the quarter of $1,559,000 or $0.03 per diluted common share, compared to $353,000 or $0.01 per diluted share in the same period in 2004. Quigley Reports 2005 Results Company reports net sales of $17.7 million for the fourth quarter compared to $17.8 million reported for the same period in 2004, with net income of $2.2 million, or $0.16 per share, compared to net income of $2.0 million, or $0.13 per share, for the same period last year. Net income gains for the fiscal year 2005 are principally attributed to the significant increase in cold-remedy sales. Quigley Reports 2005 Results Company reports net sales of $17.7 million for the fourth quarter compared to $17.8 million reported for the same period in 2004, with net income of $2.2 million, or $0.16 per share, compared to net income of $2.0 million, or $0.13 per share, for the same period last year. Net income gains for the fiscal year 2005 are principally attributed to the significant increase in cold-remedy sales. Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm) Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years. Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm) Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years. Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm) Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years. Forbes Medi-Tech Agrees To Sell Sterol Manufacturing Interest for US$25 million and Signs 5 Year Supply Agreement for Reducol(tm) Company has announced that it has agreed to sell its interest in Phyto-Source LP, the Company's 50-50 sterol manufacturing joint venture, for US$25 million to Chusei Oil Co. Ltd., and that Phyto-Source and Forbes Medi-Tech signed a supply agreement which will assure Forbes Medi-Tech of a supply of Reducol(tm) and other wood sterols for a period of 5 years. Burcon granted two U.S. patents Company receives United States Patent Number 6,992,173 B2 - "Protein Extraction from Canola Oil Seed Meal" - covering an improved process for the recovery of protein from canola oil seed meal and other oil seed meals, and United States Patent Number 7,001,990 - "Canola Protein Isolate Functionality II" - covering a protein isolate, obtained from canola oil seed meal, as a functional component in food compositions. Burcon granted two U.S. patents Company receives United States Patent Number 6,992,173 B2 - "Protein Extraction from Canola Oil Seed Meal" - covering an improved process for the recovery of protein from canola oil seed meal and other oil seed meals, and United States Patent Number 7,001,990 - "Canola Protein Isolate Functionality II" - covering a protein isolate, obtained from canola oil seed meal, as a functional component in food compositions. Investment To Enable Functional Foods Clinical Trials for Vital Foods BioPacificVentures (BPV), the $100 million Australasian food, health and agbio venture capital fund, is leading a $4 million investment round in the Auckland-based functional food manufacturer Vital Food Processors Ltd with Seeka Kiwifruit Industries Ltd as co-investor, allowing Vital to conduct clinical trials with its products for digestive disorders and to expand its international marketing. Investment To Enable Functional Foods Clinical Trials for Vital Foods BioPacificVentures (BPV), the $100 million Australasian food, health and agbio venture capital fund, is leading a $4 million investment round in the Auckland-based functional food manufacturer Vital Food Processors Ltd with Seeka Kiwifruit Industries Ltd as co-investor, allowing Vital to conduct clinical trials with its products for digestive disorders and to expand its international marketing. Advitech’s Dermylex(TM) To Be Marketed by PhotoMedex in five U.S. areas by end of February 2006 PhotoMedex Inc. will pre-launch Dermylex(TM) in five U.S. areas (San Francisco, CA, Los Angeles, CA, Dallas, TX, New York, NY and Cleveland, OH) during the last week of February 2006, will also introduce Dermylex™ at the American Academy of Dermatology (AAD) Conference. Advitech’s Dermylex(TM) To Be Marketed by PhotoMedex in five U.S. areas by end of February 2006 PhotoMedex Inc. will pre-launch Dermylex(TM) in five U.S. areas (San Francisco, CA, Los Angeles, CA, Dallas, TX, New York, NY and Cleveland, OH) during the last week of February 2006, will also introduce Dermylex™ at the American Academy of Dermatology (AAD) Conference. Atrium Reports Fiscal 2005 Results Company reports revenues of US$201 million for the year ended December 31, 2005, up 47% from US$136 million for the corresponding previous fiscal year, with net earnings increasing 42% to US$14.3 million for the year ended December 31, 2005, compared to US$10.1 million for the same period last year. Atrium Reports Fiscal 2005 Results Company reports revenues of US$201 million for the year ended December 31, 2005, up 47% from US$136 million for the corresponding previous fiscal year, with net earnings increasing 42% to US$14.3 million for the year ended December 31, 2005, compared to US$10.1 million for the same period last year. Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors. Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors. Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors. Thomas Doorley III, Global Growth Strategist, Joins Natrol Board of Directors Company announces that Thomas Doorley III, CEO and co-founder of Sage Partners, LLC, has joined Natrol's Board of Directors. EPAX AS Announces De-merger with Pronova Biocare EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name. EPAX AS Announces De-merger with Pronova Biocare EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name. EPAX AS Announces De-merger with Pronova Biocare EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name. EPAX AS Announces De-merger with Pronova Biocare EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name. EPAX AS Announces De-merger with Pronova Biocare EPAX AS, formerly a division of Pronova Biocare, announced today a recent de-merger from its previous parent company, as it will continue to produce its high quality, high purity oils under the EPAX brand name. Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors. Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors. Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors. Dr. Joe M. Mccord Joins Lifeline Therapeutics, Inc. Board Of Directors Dr. Joe McCord, the Company's Director of Science, has been named to its Board of Directors. Reliv International Announces 2005 and Q4 Results Company reports Q4 net income of $1.81 million, or $0.11 per share (diluted), compared to $1.28 million, or $0.07 per share (diluted) in the prior-year period, on sales of $27.5 million, compared to $25.4 million in the fourth quarter of 2004. Reliv International Announces 2005 and Q4 Results Company reports Q4 net income of $1.81 million, or $0.11 per share (diluted), compared to $1.28 million, or $0.07 per share (diluted) in the prior-year period, on sales of $27.5 million, compared to $25.4 million in the fourth quarter of 2004. Planet Organic Health Corp Announces Second Quarter Results Company reports net income of $498,966 versus a loss of ($69,393) for the same period last year, on sales of $9.1 million for the period; an increase of 51.7%. Planet Organic Health Corp Announces Second Quarter Results Company reports net income of $498,966 versus a loss of ($69,393) for the same period last year, on sales of $9.1 million for the period; an increase of 51.7%. NutraCea Announces Kody Newland Senior Vice President of Sales Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets. NutraCea Announces Kody Newland Senior Vice President of Sales Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets. NutraCea Announces Kody Newland Senior Vice President of Sales Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets. NutraCea Announces Kody Newland Senior Vice President of Sales Company announces the hiring of Kody Newland as Senior V.P. of Sales, bringing over 27 years of sales and marketing experience in the both the private and public markets. Hain Celestial Acquires The Business and Assets of Para Laboratories Company announces the acquisition of the business and assets of Para Laboratories, Inc. including the Queen Helene(R), Batherapy(R) and Footherapy(R) brands of health and beauty products for professional and personal use. Hain Celestial Acquires The Business and Assets of Para Laboratories Company announces the acquisition of the business and assets of Para Laboratories, Inc. including the Queen Helene(R), Batherapy(R) and Footherapy(R) brands of health and beauty products for professional and personal use. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	MATAWAN, N.J., Feb 23, 2006 (BUSINESS WIRE) -- PacificHealth Laboratories, Inc. (PHLI) , a leading nutrition technology company, announced that Mott's LLP, has purchased the trademarks, technology and patents for their brands, Accelerade(R) and Endurox (R) R4 (R). Under the terms of the purchase PacificHealth Laboratories received a $4 million upfront payment and a royalty based on sales for a defined period. Additionally, PacificHealth Laboratories was granted an exclusive royalty-free license to use the intellectual property and trademarks for the continued manufacture, distribution and marketing of Accelerade and Endurox R4 brands in powder and gel forms. Dr. Robert Portman, CEO and President of PHLI said, "We are delighted to complete this transaction with Motts. Serious athletes have recognized for quite some time the science-based advantages of Accelerade. This agreement will give PHLI the necessary resources to grow the Accelerade powder and gel business. Our goal is to make sure that athletes at all levels, in all sports, and all ages including the weekend warrior will experience the performance benefits of this exceptional sports drink." PacificHealth Laboratories has been a pioneer in the development of a new generation of protein-containing sports and recovery drinks that have been shown, in head-to-head comparisons with conventional sports drinks, to improve endurance, enhance rehydration, reduce muscle damage and speed muscle recovery following exercise. PHLI's research program in sports drinks has resulted in two patents and over 18 published studies demonstrating the benefits of adding protein to a sports drink. Dr. Portman continued, "This agreement also gives PHLI the additional funds necessary to expand our research programs and accelerate product development in weight loss and management of type II diabetes. The improved form of our appetite suppressant should be launched in the third quarter of 2006 under the brand name Satietrim(R). Incorporating a patented nutritional formulation, Satietrim has been shown in clinical studies to reduce food intake up to 20%." About PacificHealth Laboratories. Inc.: PacificHealth Laboratories, Inc. (PHLI.OB), a leading nutrition technology company, has been a pioneer in discovering and developing patented, protein-based nutritional products that stimulate specific peptides involved in appetite regulation and that activate biochemical pathways involved in muscle performance and growth. PHLI's principle areas of focus include weight loss, management of Type 2 diabetes and sports performance. To learn more, visit www.pacifichealthlabs.com. Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software